Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice

[1]  D. Thijssen,et al.  A systematic review and meta‐analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[2]  J. Godos,et al.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials , 2016, Therapeutic advances in gastroenterology.

[3]  O. Yokosuka,et al.  Palmitate-induced Regulation of PPARγ via PGC1α: a Mechanism for Lipid Accumulation in the Liver in Nonalcoholic Fatty Liver Disease , 2016, International journal of medical sciences.

[4]  D. Erion,et al.  Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice. , 2016, Endocrinology.

[5]  O. Yokosuka,et al.  Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. , 2015, World journal of gastroenterology.

[6]  H. Gerstein,et al.  Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. , 2015, The Biochemical journal.

[7]  H. Vali,et al.  A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[8]  H. Yki-Järvinen.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.

[9]  Kui-Jin Kim,et al.  Codonopsis lanceolata Extract Prevents Diet-Induced Obesity in C57BL/6 Mice , 2014, Nutrients.

[10]  Jiajun Zhao,et al.  Peroxisome Proliferator-Activated Receptor α Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect , 2014, PloS one.

[11]  L. Rui,et al.  Energy metabolism in the liver. , 2014, Comprehensive Physiology.

[12]  M. Do,et al.  The Korean Mistletoe (Viscum album coloratum) Extract Has an Antiobesity Effect and Protects against Hepatic Steatosis in Mice with High-Fat Diet-Induced Obesity , 2013, Evidence-based complementary and alternative medicine : eCAM.

[13]  Soyoung Kim,et al.  Involvement of SIRT1-AMPK signaling in the protective action of indole-3-carbinol against hepatic steatosis in mice fed a high-fat diet. , 2013, The Journal of nutritional biochemistry.

[14]  Z. Halpern,et al.  Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. , 2012, Journal of hepatology.

[15]  Mark P. Jedrychowski,et al.  Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis , 2011, The EMBO journal.

[16]  Hiroyasu Ito,et al.  l-Tryptophan-mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mammalian Target of Rapamycin* , 2011, The Journal of Biological Chemistry.

[17]  Y. Barak,et al.  Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  L. Videla,et al.  Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. , 2011, The Journal of clinical endocrinology and metabolism.

[19]  Ken-ichi Watanabe,et al.  Sake Lees Fermented with Lactic Acid Bacteria Prevents Allergic Rhinitis-Like Symptoms and IgE-Mediated Basophil Degranulation , 2011, Bioscience, biotechnology, and biochemistry.

[20]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[21]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[22]  E. Brunt,et al.  Nonalcoholic fatty liver disease: pathology and pathogenesis. , 2010, Annual review of pathology.

[23]  R. Ross,et al.  The future of obesity reduction: beyond weight loss , 2009, Nature Reviews Endocrinology.

[24]  Youming Li,et al.  A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non‐alcoholic fatty liver disease and decreased waist circumference and waist‐to‐hip ratio , 2008, Journal of gastroenterology and hepatology.

[25]  M. Yeh,et al.  Pathology of nonalcoholic fatty liver disease. , 2007, American journal of clinical pathology.

[26]  William Caplan,et al.  Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. , 2007, Journal of the American Dietetic Association.

[27]  K. Kotoh,et al.  Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. , 2007, International journal of molecular medicine.

[28]  H. Izu,et al.  Sake Yeast Suppresses Acute Alcohol-Induced Liver Injury in Mice , 2006, Bioscience, biotechnology, and biochemistry.

[29]  U. Edvardsson,et al.  Insulin and oleic acid increase PPARγ2 expression in cultured mouse hepatocytes , 2006 .

[30]  Ying Wang,et al.  TEAVIGOTM (Epigallocatechin Gallate) Supplementation Prevents Obesity in Rodents by Reducing Adipose Tissue Mass , 2005, Annals of Nutrition and Metabolism.

[31]  K. Choi,et al.  Reduced expression of peroxisome proliferator‐activated receptor‐α may have an important role in the development of non‐alcoholic fatty liver disease , 2004, Journal of gastroenterology and hepatology.

[32]  Y. Manabe,et al.  Relationship between the Preference for Sake (Japanese rice wine) and the Movements of Metabolic Parameters Coinciding with Sake Intake , 2004, Bioscience, biotechnology, and biochemistry.

[33]  Y. Terauchi,et al.  The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance* , 2001, The Journal of Biological Chemistry.

[34]  J. Auwerx,et al.  PPAR gamma: an essential role in metabolic control. , 2001, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[35]  R. Chalkley,et al.  Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism , 2000, Molecular and Cellular Biology.

[36]  Satoshi Tanaka,et al.  PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance , 1999 .

[37]  K. Umesono,et al.  Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.

[38]  Nobuo Tsutsui,et al.  Protein-nutritive assessment of sake lees obtained by brewing from liquefied rice. , 1998, Journal of nutritional science and vitaminology.

[39]  W. Miller,et al.  A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention , 1997, International Journal of Obesity.

[40]  S. Imayasu,et al.  Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. , 1994, Bioscience, biotechnology, and biochemistry.

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[42]  U. Edvardsson,et al.  Insulin and oleic acid increase PPARgamma2 expression in cultured mouse hepatocytes. , 2006, Biochemical and biophysical research communications.

[43]  Y. Terauchi,et al.  The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. , 2001, The Journal of biological chemistry.

[44]  T Hashimoto,et al.  Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. , 2001, Annual review of nutrition.

[45]  T. Hashimoto,et al.  PEROXISOMAL β-OXIDATION AND PEROXISOME PROLIFERATOR–ACTIVATED RECEPTOR α: An Adaptive Metabolic System , 2001 .

[46]  S. Aizawa,et al.  PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. , 1999, Molecular cell.